Chronicles Research will participate in the 5th International Conference “Evolution of Clinical Research in the Era of Digital Technologies”. The conference will bring together leading experts from the pharmaceutical industry, representatives of regulatory authorities from EAEU countries, pharmaceutical companies, research centers, bioanalytical laboratories, IT solution providers, and clinical research professionals.

For Chronicles, participation in this event provides an opportunity to discuss key industry developments and share our vision for the future of digital quality management in clinical research. The company’s CEO will deliver a presentation titled “Digital Transformation of the Quality Management System in Clinical Research,” focusing on modern approaches to process automation, risk management, and ensuring compliance with evolving international requirements.

Today, the pharmaceutical industry is undergoing a significant transformation. The transition from ICH GCP R2 to ICH GCP R3, the exponential growth of data volumes, the expansion of decentralized clinical trials, and the adoption of artificial intelligence are driving organizations to rethink traditional quality management approaches. As a result, digital documentation, process transparency, data privacy protection, and effective collaboration among stakeholders have become critical priorities.

Among the key topics of the conference are digital technologies and artificial intelligence as tools for resource optimization, risk-based approaches to clinical research, audits and inspections under new regulatory conditions, and the use of real-world clinical data. These areas are highly relevant to Chronicles, whose solutions are designed to improve quality, transparency, and operational efficiency throughout the clinical research lifecycle.

Particular attention across the industry is currently focused on the integration of digital platforms, automation of CAPA processes, risk management, and inspection readiness. For clinical research organizations and pharmaceutical companies, these capabilities are no longer optional innovations but essential elements of sustainable growth and global competitiveness.

Participation in the conference will enable Chronicles Research not only to present its expertise and experience but also to engage with industry leaders on practical strategies for building a modern digital ecosystem for clinical research. In a rapidly evolving environment, events such as this play a vital role in knowledge sharing, partnership development, and the identification of innovative solutions that will shape the future of clinical research.